Abstract
In a 15-week double-blind, placebo-controlled, crossover study both carteolol 2% and timolol 0.5% produced a significant reduction in intraocular pressure. Twelve hours after administration the reduction in pressure on carteolol was significantly less than that obtained on timolol.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Duff G. R., Graham P. A. A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure. Br J Ophthalmol. 1988 Jan;72(1):27–28. doi: 10.1136/bjo.72.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kitazawa Y., Azuma I., Takase M., Komemushi S. [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)]. Nippon Ganka Gakkai Zasshi. 1981;85(7):798–804. [PubMed] [Google Scholar]
- Negishi C., Ueda S., Kanai A., Nakajima A., Funahashi M., Kitazawa Y., Komemushi S. [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)]. Nippon Ganka Gakkai Zasshi. 1981 Jan;85(1):57–66. [PubMed] [Google Scholar]